James Paul Lang Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Paul Lang.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Paul Lang. James Paul Lang is Director in OptimizeRx Corp ($OPRX) and Director in BIOVIE INC. ($BIVI).
Latest Insider Trading Transactions of James Paul Lang
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 539 | 0 | 32,253 | 31.7 K to 32.3 K (+1.70 %) |
| Mar 04 2021 | BIVI | BIOVIE INC. | Lang James Paul | Director | Option Exercise | A | 13.91 | 99,000 | 1,377,090 | 120,988 | |
| Jan 20 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 802 | 0 | 31,714 | 30.9 K to 31.7 K (+2.59 %) |
| Jan 20 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 1,183 | 0 | 30,912 | 29.7 K to 30.9 K (+3.98 %) |
| Jul 02 2020 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 1,937 | 0 | 29,729 | 27.8 K to 29.7 K (+6.97 %) |
| Mar 31 2020 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,784 | 0 | 27,792 | 25 K to 27.8 K (+11.13 %) |
| Jan 07 2020 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 25,008 | 22.9 K to 25 K (+9.09 %) |
| Oct 02 2019 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 22,924 | 20.8 K to 22.9 K (+10.00 %) |
| Mar 29 2019 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 14,585 | 12.5 K to 14.6 K (+16.67 %) |
| Feb 05 2019 | BIVI | BIOVIE INC. | Lang James Paul | Director | Grant | A | 0.04 | 200,000 | 7,000 | 450,000 | 250 K to 450 K (+80.00 %) |
| Nov 01 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Option Exercise | A | 0.02 | 2,000,000 | 36,000 | 2,548,485 | |
| Nov 01 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Grant | A | 1.50 | 20,000 | 30,000 | 20,000 | 0 to 20 K |
| Oct 12 2018 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 12,501 | 10.4 K to 12.5 K (+20.01 %) |
| Aug 15 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Option Exercise | A | 0.10 | 100,000 | 10,000 | 548,485 | |
| Aug 15 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Option Exercise | A | 0.15 | 166,667 | 25,000 | 448,485 | |
| Aug 15 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Option Exercise | A | 0.60 | 56,818 | 34,091 | 281,818 | |
| Aug 15 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Option Exercise | A | 0.21 | 100,000 | 21,000 | 225,000 | |
| Aug 15 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Grant | A | 0.15 | 200,000 | 30,000 | 730,303 | 530.3 K to 730.3 K (+37.71 %) |
| Aug 15 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Grant | A | 0.15 | 166,667 | 25,000 | 530,303 | 363.6 K to 530.3 K (+45.83 %) |
| Aug 15 2018 | BIVI | BIOVIE INC. | Lang James Paul | Director | Grant | A | 0.22 | 113,636 | 25,000 | 363,636 | 250 K to 363.6 K (+45.45 %) |
| Jul 03 2018 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 10,417 | 8.3 K to 10.4 K (+25.01 %) |
| Jan 12 2018 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 25,000 | 18.8 K to 25 K (+33.33 %) |
| Oct 02 2017 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 18,750 | 12.5 K to 18.8 K (+50.00 %) |
| Jun 30 2017 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 12,500 | 6.3 K to 12.5 K (+100.00 %) |
| Apr 06 2017 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
Page: 1